Kwang Sung Kim;Yang Je Cho;Jin Wook Jang;Na Gyong Lee;Won II Yoo
发明人:
Yang Je Cho,Na Gyong Lee,Jin Wook Jang,Kwang Sung Kim,Won II Yoo
申请号：
US13995188
公开号：
US09572877B2
申请日:
2011.12.17
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to a pharmaceutical vaccine composition comprising: (a) a pathogen-derived antigen selected from the group consisting of Mycobacterium tuberculosis antigen, Bacillus anthracis antigen, HAV (hepatitis A virus) antigen, HBV (hepatitis B virus) antigen, HCV (hepatitis C virus) antigen, HIV (human immunodeficiency virus) antigen, influenza virus antigen, HSV (herpes simplex virus) antigen, Hib (Haemophilus influenzae type b) antigen, Neisseria meningitidis antigen, Corynebacterium diphtheriae antigen, Bordetella pertussis antigen, Clostridium tetani antigen and Varicella virus antigen； (b) a deacylated non-toxic LOS (lipooligosaccharide)； and (c) a pharmaceutically acceptable carrier.
